Oakridge International Limited (U9O0.F)
EUR 0.04
(7.69%)
EUR 0.04
(7.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -761.24 Thousand AUD | -555.62% |
| 2023 | -116.11 Thousand AUD | 78.13% |
| 2022 | -531.03 Thousand AUD | -188.03% |
| 2021 | 603.21 Thousand AUD | 554.39% |
| 2020 | -132.75 Thousand AUD | 0.0% |
| 2019 | -132.75 Thousand AUD | 98.43% |
| 2018 | -8.45 Million AUD | 22.16% |
| 2017 | -10.86 Million AUD | -252.01% |
| 2016 | -3.08 Million AUD | -5.58% |
| 2015 | -2.92 Million AUD | -231.7% |
| 2014 | -881.4 Thousand AUD | 75.75% |
| 2013 | -3.63 Million AUD | 87.18% |
| 2012 | -28.34 Million AUD | -1389.29% |
| 2011 | -1.9 Million AUD | 49.75% |
| 2010 | -3.78 Million AUD | -126.07% |
| 2009 | -1.67 Million AUD | 26.83% |
| 2008 | -2.28 Million AUD | -402.8% |
| 2007 | -455.35 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -283.6 Thousand EUR | 0.0% |
| 2024 Q4 | -187.59 Thousand EUR | 0.0% |
| 2023 FY | -116.11 Thousand AUD | 78.13% |
| 2023 Q4 | 24.68 Thousand EUR | 124.77% |
| 2023 Q2 | -99.66 Thousand EUR | -18.62% |
| 2022 Q2 | -257.49 Thousand EUR | -50.33% |
| 2022 Q4 | -84.01 Thousand EUR | 67.37% |
| 2022 FY | -531.03 Thousand AUD | -188.03% |
| 2021 FY | 603.21 Thousand AUD | 554.39% |
| 2021 Q4 | -171.28 Thousand EUR | -131.08% |
| 2021 Q2 | 551.06 Thousand EUR | 234.93% |
| 2020 Q2 | 334.09 Thousand EUR | 114.9% |
| 2020 Q4 | -408.41 Thousand EUR | -222.25% |
| 2020 FY | -132.75 Thousand AUD | 0.0% |
| 2019 Q4 | -2.24 Million EUR | 0.0% |
| 2019 FY | -132.75 Thousand AUD | 98.43% |
| 2018 FY | -8.45 Million AUD | 22.16% |
| 2017 FY | -10.86 Million AUD | -252.01% |
| 2016 FY | -3.08 Million AUD | -5.58% |
| 2015 FY | -2.92 Million AUD | -231.7% |
| 2014 FY | -881.4 Thousand AUD | 75.75% |
| 2013 FY | -3.63 Million AUD | 87.18% |
| 2012 FY | -28.34 Million AUD | -1389.29% |
| 2011 FY | -1.9 Million AUD | 49.75% |
| 2010 FY | -3.78 Million AUD | -126.07% |
| 2009 FY | -1.67 Million AUD | 26.83% |
| 2008 FY | -2.28 Million AUD | -402.8% |
| 2007 FY | -455.35 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| DocCheck AG | 2.27 Million EUR | 133.514% |
| CompuGroup Medical SE & Co. KGaA | 45.91 Million EUR | 101.658% |
| MeVis Medical Solutions AG | 4.91 Million EUR | 115.474% |
| Nexus AG | 24.03 Million EUR | 103.168% |